2018
DOI: 10.1016/j.partic.2017.10.002
|View full text |Cite
|
Sign up to set email alerts
|

Fabrication of core–shell PLGA/PLA–pNIPAM nanocomposites for improved entrapment and release kinetics of antihypertensive drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 25 publications
(7 citation statements)
references
References 25 publications
0
5
0
1
Order By: Relevance
“…This model has been widely and effectively used for the description of drug administration through polymeric matrices. An example, for the same type of polymer as the one discussed in this work, is the release of ramipril encapsulated in PLA and PLGA nanospheres, which was studied by Basu and coworkers [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…This model has been widely and effectively used for the description of drug administration through polymeric matrices. An example, for the same type of polymer as the one discussed in this work, is the release of ramipril encapsulated in PLA and PLGA nanospheres, which was studied by Basu and coworkers [ 51 ].…”
Section: Discussionmentioning
confidence: 99%
“…Regarding pure PLGA, the UV–vis absorption spectrum revealed bands at 250 nm [ 45 ], as reported in the literature. Focusing on the WZ-PLGA system, the absence of bands attributed to the WZ polymorph in the spectrum indicated the encapsulation of the PLGA shell and on the hexagonal P6₃mc surface.…”
Section: Resultsmentioning
confidence: 85%
“…It turned out that both particles with a pNIPAM shell had higher encapsulation efficiency than the conventional PLGA core (52.4%) and PLA core (47.42%). In addition, within 24 h, the PLGA-pNIPAM core-shell microparticles demonstrated a sustained releasing pattern of 86% of the model drug [47].…”
Section: Drug Deliverymentioning
confidence: 95%